Caroline François Piau

Dr. Caroline François Piau

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
MBMarion Beviere
Marion Beviere
SRSophie Reissier
Sophie Reissier
MPMalo PENVEN
Malo PENVEN
LDLoren Dejoies
Loren Dejoies
FGFrançois Guérin
François Guérin
CPCaroline François Piau
Caroline François Piau
Next-generation sequencing (NGS) has modernized the field of tuberculosis (TB) research by enabling high-throughput sequencing of the entire genome of Mycobacterium tuberculosis (MTB), which is the causative agent of TB. NGS has provided insights into the genetic diversity of MTB, which are crucial for understanding the evolution and transmission of the disease, and it has facilitated the identification of drug-resistant strains, enabling rapid and accurate tailoring of treatment. However, the high cost and the technical complexities of NGS currently limit its widespread use in clinical settings. International recommendations are thus necessary to facilitate the interpretation of polymorphisms, and an experimental approach is still necessary to correlate them to phenotypic data. This review aims to present a comparative, step-by-step, and up-to-date review of the techniques available for the implementation of this approach in routine laboratory workflow. Ongoing research on NGS for TB holds promise for improving our understanding of the disease and for developing more efficacious treatments.

1 March 2015 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
CPCaroline François Piau
Caroline François Piau
MKMallorie Kerjouan
Mallorie Kerjouan
MMMarc Le Mouel
Marc Le Mouel
SPSolene Patrat-Delon
Solene Patrat-Delon
PHPierre-Louis Henaux
Pierre-Louis Henaux
SKSamer Kayal
Samer Kayal
Here we report in a human, a renal transplant patient, the first disseminated infection with Nocardia cerradoensis , isolated after a brain biopsy. Species identification was based on 16S rRNA, gyrB , and hsp65 gene analyses. Antibiotic treatment was successful by combining carbapenems and aminoglycosides and then switching to oral trimethoprim-sulfamethoxazole.

23 August 2021 in Journal of Leukocyte Biology
Verified
Journal Article
Closed access
PDF file
MLMathieu Lesouhaitier
Mathieu Lesouhaitier
MGMurielle Gregoire
Murielle Gregoire
AGarnaud Gacouin
arnaud Gacouin
VCValentin Coirier
Valentin Coirier
AFAurélien Frerou
Aurélien Frerou
JTJean-Marc Tadié
Jean-Marc Tadié

1 August 2024 in Access Microbiology
Verified
Journal Article
Open access
ATAdrien Turban
Adrien Turban
VJVincent Joussellin
Vincent Joussellin
CPCaroline François Piau
Caroline François Piau
Vincent CattoirVincent Cattoir
Vincent Cattoir
YLYoann Launey
Yoann Launey
GEGabriel Eustache
Gabriel Eustache
Clostridium septicum gas gangrene is a severe and deadly infection caused by an anaerobic, spore-forming, Gram-positive bacillus. As previously described, two entities are observed: traumatic and spontaneous (or non-traumatic) forms. In this report, we aim to describe the case of a fulminant and ultimately fatal C. septicum myonecrosis occurring in a patient who was first admitted for refractory cardiac arrest and placed on veino-arterial extracorporeal membrane oxygenation (ECMO). Building upon prior studies that have documented cases of spontaneous gas gangrene caused by C. septicum, we provide an updated compilation, focusing on microbiological characteristics of C. septicum, along with the diagnostic and therapeutic challenges associated with spontaneous gas gangrene. Additionally, the specific clinical situation of our case illustrates the seriousness of this infectious complication that combined both spontaneous and traumatic gas gangrene risk factors. We thus, discuss the antibiotic coverage prior to the initiation of ECMO procedure.

14 June 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
IBIsabelle Bonnet
Isabelle Bonnet
EHElie Haddad
Elie Haddad
LGLorenzo Guglielmetti
Lorenzo Guglielmetti
PBPascale Bemer
Pascale Bemer
LBLouis Bernard
Louis Bernard
AAAlexandra Aubry
Alexandra Aubry
The optimal treatment for osteoarticular infection due to multidrug-resistant tuberculosis strains (MDR-OATB) remains unclear. This study aims to evaluate the diagnosis, management and outcome of MDR-OATB in France. We present a case series of MDR-OATB patients reviewed at the French National Reference Center for Mycobacteria between 2007 and 2018. Medical history and clinical, microbiological, treatment and outcome data were collected. Twenty-three MDR-OATB cases were reported, representing 3% of all concurrent MDR-TB cases in France. Overall, 17 were male, and the median age was 32 years. Six patients were previously treated for TB, including four with first-line drugs. The most frequently affected site was the spine (n = 16). Bone and joint surgery were required in 12 patients. Twenty-one patients (91%) successfully completed the treatment with a regimen containing a mean of four drugs (range, 2–6) for a mean duration of 20 months (range, 13–27). Overall, high rates of treatment success were achieved following WHO MDR-TB treatment guidelines and individualized patient management recommendations by the French National TB Consilium. However, the optimal combination of drugs, duration of treatment and role of surgery in the management of MDR-OATB remains to be determined.